DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bartlett JM, Munro A, Cameron DA et al.
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
J Clin Oncol 2008;
26: 5027-5035
DOI: 10.1200/JCO.2007.14.6597.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.